Cancers, Free Full-Text

Por um escritor misterioso

Descrição

As lung cancer has the highest cancer-specific mortality rates worldwide, there is an urgent need for new therapeutic and diagnostic approaches to detect early-stage tumors and to monitor their response to the therapy. In addition to the well-established tissue biopsy analysis, liquid-biopsy-based assays may evolve as an important diagnostic tool. The analysis of circulating tumor DNA (ctDNA) is the most established method, followed by other methods such as the analysis of circulating tumor cells (CTCs), microRNAs (miRNAs), and extracellular vesicles (EVs). Both PCR- and NGS-based assays are used for the mutational assessment of lung cancer, including the most frequent driver mutations. However, ctDNA analysis might also play a role in monitoring the efficacy of immunotherapy and its recent accomplishments in the landscape of state-of-the-art lung cancer therapy. Despite the promising aspects of liquid-biopsy-based assays, there are some limitations regarding their sensitivity (risk of false-negative results) and specificity (interpretation of false-positive results). Hence, further studies are needed to evaluate the usefulness of liquid biopsies for lung cancer. Liquid-biopsy-based assays might be integrated into the diagnostic guidelines for lung cancer as a tool to complement conventional tissue sampling.
Cancers, Free Full-Text
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancer Free Posters for Sale
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancers, Free Full-Text
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Cancers, Free Full-Text
8 Ways to prevent cancer & be healthy -Siteman Cancer Center
Cancers, Free Full-Text
Cancer-Free with Food: A Step-by-Step by Werner Gray, Liana
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancers, Free Full-Text
Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early-stage lung cancer and postoperative minimal residual disease - eBioMedicine
Cancers, Free Full-Text
Particle Illusion 3.02 Download - Colaboratory
de por adulto (o preço varia de acordo com o tamanho do grupo)